MECHANISM OF WEIGHT GAIN SUPPRESSING EFFECT OF ER-40133, AN ANGIOTENSIN I CONVERTING ENZYME INHIBITOR, IN GROWING RATS
スポンサーリンク
概要
- 論文の詳細を見る
Effects of ER-40133, an inhibitor of angiotensin converting enzyme (ACE), on weight gain and sodium and potassium balance were studied in growing SD male rats. Thirty-two animals (seven weeks of age) were divided into two groups; one received a standard diet containing 0.227% sodium and the other a low (0.0657%) sodium diet. They were divided into four subgroups; one control group and three treated groups receiving 3,10 or 30 mg/kg of ER-40133, by gavage, once a day for five consecutive days. Body weight gain (average of the standard and low sodium diet groups) was -32% in the 3 mg/kg group, -74% in 10 mg/kg group and -99% in 30 mg/kg group, when compared with the control group. There was a highly linear correlation between suppression of body weight gain and reduction in sodium and potassium retention for both groups of animals given the standard and low sodium diet. The reduced sodium retention, the primary effect of ACE inhibitors, accounted for about 30% of suppressed weight gain, and the reduced potassium retention, the secondary effect of sodium deficiency, could account for the rest about 70% of weight suppression by ER-40133.
- 日本トキシコロジー学会の論文
著者
-
TSUKIDATE Kazuo
Drug Safety Research Laboratories, Eisai Co., Ltd
-
TORITSUKA Naoki
Toxicogenomics Project, National Institute of Biomedical Innovation
-
Torituka Naoki
Toxicogenomics Project National Institute Of Biomedical Innovation
-
Toritsuka Naoki
Drug Safety And Disposition Research Laboratories Eisai Co. Ltd.
-
Toritsuka Naoki
Drug Safety Research Labolatories Eisai Co. Ltd.
-
IGARASHI Toshiji
Drug Safety Research Labolatories, Eisai Co.,Ltd.
-
Tsukidate Kazuo
Drug Safety Research Lab. Eisai Co. Ltd.
-
Tsukidate Kazuo
Drug Safety Research Labolatories Eisai Co. Ltd.
-
Igarashi Toshiji
Drug Safety Research Labolatories Eisai Co. Ltd.
関連論文
- A new method for preparing electron microscopic specimens of Helicobacter pylon
- P-15 Investigational study for hepatotoxicity in rats by E2011 repeated administration. 2) Bioactivation of benzothiazoles with amine structures in the Ames mutagenicity assay.(Proceedings of the 27th Annual Meeting)
- GENE EXPRESSION PROFILE IN LIVER OF DIFFERING AGES OF RATS AFTER SINGLE ORAL ADMINISTRATION OF ACETAMINOPHEN
- P6-56 Influence of orally-administered vehicles on gene expression analyzed by DNA microarray(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-55 Drug Induced Cytotoxicity Affects Gene Expression Profile in Primary Cultured Rat Hepatocytes : A DNA Microarray Analysis(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-54 DNAmicroarray analysis of time-dependent change of gene expression in rat primary hepatocyte cultured in serum-containing or-free medium(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-53 Comparison of gene expression profile of the liver after Phenobarbital treatment in vivo and in vitro(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- P6-51 Gene Expression Profile in the Liver from Different Age of Rats after Single Oral Dose of Acetaminophen(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- MECHANISM OF WEIGHT GAIN SUPPRESSING EFFECT OF ER-40133, AN ANGIOTENSIN I CONVERTING ENZYME INHIBITOR, IN GROWING RATS
- P-11 Application of hepatocytes cultured in a sandwich configuration to toxicity assessment.(Proceedings of the 27th Annual Meeting)
- P8-43 Study on the difference of CK activity between plasma and serum in monkey(BLOOD/TOXICOKINETICS/OTHERS-2)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Mechanism for benzothiazole derivative-induced hepatotoxicity in rats(SYMPOSIUM 1 : MECHANISMS OF HEPATOTOXIC EFFECTS)
- TOXICOLOGICAL RESPONSE OF RATS TO A NOVEL MONOAMINE OXIDASE TYPE-A INHIBITOR, (5R)-3-[2-((1S)-3-CYANO-1-HYDROX-YPROPYL)BENZOTHIAZOL-6-YL]-5-METHOXYMETHYL-2-OXAZOLIDI-NONE (E2011), ORALLY ADMINISTERED FOR 13 WEEKS
- "A-4 Mechanisms of cytotoxicity of cultured rat hepatocytes by naphthoquinones.